Cargando…
Cardiovascular manifestations and treatment considerations in COVID-19
Since its recognition in December 2019, covid-19 has rapidly spread globally causing a pandemic. Pre-existing comorbidities such as hypertension, diabetes, and cardiovascular disease are associated with a greater severity and higher fatality rate of covid-19. Furthermore, COVID-19 contributes to car...
Autores principales: | Kang, Yu, Chen, Tiffany, Mui, David, Ferrari, Victor, Jagasia, Dinesh, Scherrer-Crosbie, Marielle, Chen, Yucheng, Han, Yuchi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211105/ https://www.ncbi.nlm.nih.gov/pubmed/32354800 http://dx.doi.org/10.1136/heartjnl-2020-317056 |
Ejemplares similares
-
Collaboration during Crisis: A Novel Point-of-Care Ultrasound Alliance among Emergency Medicine, Internal Medicine, and Cardiology in the COVID-19 Era
por: Panebianco, Nova, et al.
Publicado: (2021) -
Ultrasound-Enhancing Agents and Associated Adverse Reactions: A Potential Connection to the COVID-19 Vaccines?
por: Soni, Meshal, et al.
Publicado: (2022) -
Comparing cardiovascular magnetic resonance strain software packages by their abilities to discriminate outcomes in patients with heart failure with preserved ejection fraction
por: Zhang, Ying, et al.
Publicado: (2021) -
Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines
por: Vidula, Mahesh K, et al.
Publicado: (2021) -
Cardiovascular Effects of CAR T Cell Therapy: A Retrospective Study
por: Lefebvre, Bénédicte, et al.
Publicado: (2020)